<DOC>
	<DOCNO>NCT00487656</DOCNO>
	<brief_summary>The purpose study see ART-123 ( recombinant human soluble thrombomodulin ) decrease number people die result Disseminated Intravascular Coagulation ( DIC ) complication sepsis .</brief_summary>
	<brief_title>Safety Efficacy ART-123 Subjects With Sepsis Disseminated Intravascular Coagulation</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Disseminated Intravascular Coagulation</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Infection suspect infection result sepsis DIC Unable provide inform consent , lack consent acceptable surrogate Subjects &lt; 18 year age Known condition could confound diagnosis DIC due sepsis Known condition increase risk bleed Known medical condition associate hypercoagulable state Known suspect severe liver disease History solid organ ( exclude uncomplicated kidney ) , bone marrow stem cell transplantation Renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>